Protecting participants of clinical trials conducted in the intensive care unit

Journal of Intensive Care Medicine

Volumn 26, Issue 4, 2011, Pages 237-249

  Flanagan, Brigid M ^a   Philpott, Sean ^b   Strosberg, Martin A ^b  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

conflict of interest; critical care research; human participants; informed consent; research ethics

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; INFORMED CONSENT; INTENSIVE CARE UNIT; LEGAL ASPECT; MEDICAL DECISION MAKING; POLICY; PRIORITY JOURNAL; REVIEW;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DECISION MAKING; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; INTENSIVE CARE UNITS; PATIENT PARTICIPATION; THERAPEUTIC EQUIPOISE;

EID: 80052102093     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610390867     Document Type: Review

References (92)

1. Monagle JF, Thomasma DC Health Care Ethics: critical Issues for 21st Century. 2nd Ed.). Sudbury, MA: Jones and Bartlett ; 2004.
2. Buchanan DR, Miller FG A public health perspective on research ethics. J Med Ethics. 2006 ; 32 (12). 729-733. (Pubitemid 46001990)
3. Veatch RM Disaster preparedness and triage: justice and the common good. Mt Sinai J Med. 2005 ; 72 (4). 236-241. (Pubitemid 41052050)
4. Marquis D. Leaving therapy to chance. Hastings Cent Rep. 1983 ; 13 (4). 40-47.
5. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987 ; 317 (3). 141-145. (Pubitemid 17092151)
6. Levine RJ Ethics and Regulation of Clinical Research. New Haven, CT: Yale University Press ; 1988.
7. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 ; 342 (18). 1301-1308.
8. Miller FG, Brody H. Clinical equipoise and the incoherence of research ethics. J Med Philos. 2007 ; 32 (2). 151-165. (Pubitemid 46598162)
9. Joffe S., Miller FG Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent Rep. 2008 ; 38 (2). 30-42.
10. Weijer C. The ethical analysis of risk in intensive care unit research. Crit Care. 2004 ; 8 (2). 85-86. (Pubitemid 38436408)
11. US National Bioethics Advisory Commission (NBAC). Assessing risks and potential benefits and evaluating vulnerability. In: Nbac, ed. Ethical and Policy Issues in Research Involving Human Participants. Washington, DC: US Government Printing Office ; 2001: 69-85. http://govinfo.library.unt.edu/nbac/ human/overvol1.pdf. Accessed May 6, 2009.
12. Emanuel EJ, Wendler D., Grady C. What makes clinical research ethical ? JAMA. 2000 ; 283: 2701-2711. (Pubitemid 30337334)
13. Halpern SP, Randolf AG, Angus DC No child left behind: Enrol-ling children and adults simultaneously in critical care randomized trials. Crit Care Med. 2009 ; 37 (9). 2638-2641.
14. Miller FG, Silverman HJ The ethical relevance of the standard of care in the design of clinical trials. Am J Resp Crit Care Med. 2004 ; 169 (5). 562-565.
15. Slutsky AS, Ranieri VM Mechanical ventilation: lessons from the ARDSNet trial. Resp Res. 2000 ; 1 (2). 73-77. (Pubitemid 34187895)
16. NIH Program on Clinical Research Policy Analysis and Coordination (CRpac) Considering Usual Care in Clinical Trial Design: scientific and Ethical Issues. Meeting proceedings November14-15, 2005. http://oba/od/nih.gov/policy/policy- issues.html. Accessed August 23, 2009.
17. Thompson BT The Acute Respiratory Network (ARDSNet): lessons Learned for the Design of Critical Care Research. Presentation at the 2005 meeting on Considering Usual Medical Care in Clinical Trial Design: Scientific and Ethical Issues. Bethesda, MD ; 2005. http://oba/od/nih.gov/policy/policy-issues.html. Accessed August 23, 2009.
18. Eichacker P. Gerstenberger EP, Banks SM, Cui X., Natanson C. Meta-Analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Resp Crit Care Med. 2003 ; 166 (1). 1510-1514.
19. Dawson L., Zarin DA, Emanuel EJ, Friedman LM, Chaudhari B., Goodman SN Considering usual medical care in clinical trial design. PLoS Med. 2009 ; 6 (9). e10000111.
20. Silverman HJ, Miller FG Control group selection in critical care randomized controlled trials evaluating interventional strategies: an ethical assessment. Crit Care Med. 2004 ; 32 (3). 852-857. (Pubitemid 38340087)
21. Takala J. Better conduct of clinical trials: the control group in critical care. Crit Care Med. 2009 ; 37 (1suppl). S80 - S90.
22. Mann H. Controversial choice of a control intervention in a trial of ventilator therapy in ARDS: standard of care arguments in a randomized controlled trial. J Med Ethics. 2005 ; 31 (9). 548-553. (Pubitemid 41301075)
23. Jonsen A. The Birth of Bioethics. New York, NY: Oxford University Press ; 1998: 134.
24. Nuremberg Military Tribunal. Trials of War Criminals before the Nuremberg Military Tribunals Under Control Council Law No10, vol 2. Washington, DC: US Government Printing Office ; 1949: 181-182.
25. Appelbaum PS, Lidz C., Meisel A. Informed Consent: Legal Theory and Clinical Practice. New York, NY: Oxford University Press ; 1989.
26. US Department of Health, Education and Welfare. Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office; 1979: 4.
27. US Department of Health and Human Services. Title 45 Part 46 (45 CFR 46; Public Welfare) Subpart A: Federal Policy for the Protection of Human Subjects. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr/46.htm. Accessed August 17, 2009.
28. Silverman HJ, Luce JM, Panken PN, et al. Recommendations for informed consent forms for critical care clinical trials. Crit Care Med. 2005 ; 33 (4). 867-882.
29. Truog RD Will ethical requirements bring critical care research to a halt ? Intensive Care Med. 2005 ; 31 (3). 338-344.
30. Luce JM Is the concept of informed consent applicable to clinical research involving critically ill patients? Crit Care Med. 2003 ; 31 (3suppl). S153 - S160.
31. Silverman HJ, Luce JM, Schwartz J. Protecting subjects with decisional impairment in research: the need for a multifaceted approach. Am J Resp Crit Care. 2004 ; 169 (1). 10-14. (Pubitemid 38233883)
32. Cohen LM, McCue JD, Green GM Do clinical and formal assessments of the capacity of patients in the intensive care unit to make decisions agree ? Arch Int Med. 1993 ; 153 (21). 2481-2485. (Pubitemid 23319875)
33. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2006 ; 163 (8). 1232-1334.
34. Appelbaum PS, Grisso T., Frank E., O'Donnell S., Kupfer DJ Competence of depressed patients for consent to research. Am J Psychiatry. 1999 ; 156 (9). 1380-1384. (Pubitemid 29416534)
35. UCSD Human Research Protections Program. Decision making capacity guidelines. http://irb.ucsd.edu/decisional.shtml. Accessed December 16, 2009.
36. Candilis PJ, Fletcher KE, Geppert CM, Lidz CW, Appelbaum PS A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill and non-ill subjects. Schizophr Res. 2008 ; 99 (1-3). 350-358.
37. Luce JM Research ethics and consent in the intensive care unit. Curr Opin Crit Care. 2003 ; 9 (6). 540-544. (Pubitemid 37518656)
38. American Thoracic Society. The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med. 2004 ; 170 (12). 1375-1384.
39. Danis M., Emanuel E., Silverman H. Ethical considerations in managing critically ill patients. In: Parillo J, Dellinger RP, eds. Critical Care Medicine: principles of Diagnosis and Management in the Adult. 3rd ed. Philadelphia, PA: Mosby ; 2001: 1509-1529.
40. OHRP Response to AHRP re: Surrogate Consent to Research. http://www.ahrp.org/ethical/CaromeARDA082802.php. Accessed January 1, 2010.
41. Resnik D. Compensation for research-related injuries: ethical and legal issues. J Legal Med. 2006 ; 27 (3). 263-287. (Pubitemid 44359747)
42. Coppolino M., Ackerson L. Do surrogate decision makers provide accurate consent for intensive care research ? Chest. 2001 ; 119 (2). 603-612. (Pubitemid 32163776)
43. US Department of Health and Human Services. Title 45 Part 46 (45 CFR 46; Public Welfare) Subpart D: Additional Protections for Children Involved as Subjects in Research. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46. htm. Accessed August 17, 2009.
44. Bigatello LM, George E., Hurford WE Ethical considerations for research in critically ill patients. Crit Care Med. 2003 ; 31 (3suppl). S178 - S181.
45. US Department of Health and Human Services. Guidance for Sponsors, Clinical Investigators and IRBs: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials. Washington, DC: US Government Printing Office ; 2008. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126489. pdf. Accessed August 20, 2009.
46. Chenaud C., Merlani P., Ricou B. Informed consent for research in ICU obtained before ICU admission. Intensive Care Med. 2006 ; 32 (3). 439-444. (Pubitemid 43289654)
47. US Food and Drug Administration. 21 CFR 50.24: Exception from Informed Consent Requirements for Emergency Research. https://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=50. Accessed August 17, 2009.
48. US Department of Health and Human Services. 45 CRF 46.101(j): To What Does This Policy Apply? http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46. htm. Accessed August 17, 2009.
49. Annane D., Outin H., Fisch C., Bellissant E. 2004. The effect of waiving consent on enrollment in a sepsis trial. Intensive Care Med. 2004 ; 30 (2). 321-324. (Pubitemid 38253426)
50. Lemaire F. A waiver for consent for intensive care research ? Intensive Care Med. 2004 ; 30 (2). 177-179. (Pubitemid 38253404)
51. Secretary's Advisory Committee on Human Research Protections (SACHRP). Meeting Minutes, March 3 and 4, 2009. Washington, DC: United States Department of Health and Human Services. http://www.hhs.gov/ohrp/sachrp. Accessed August 20, 2009.
52. Applebaum PS, Roth LH, Lidz C. The therapeutic misconception: informed consent in psychiatric research. Int J Law Psychiatry. 1982 ; 5 (3-4). 319-329.
53. Appelbaum PS, Roth LH, Lidz CW, Benson P., Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987 ; 17 (2). 20-24.
54. National Bioethics Advisory Commission. Ethical and Policy issues in International Research: Clinical Trials in Developing Countries. Washington, DC: US Government Printing Office ; 2001. http://bioethics.georgetown.edu/nbac/ clinical/ExecSum.pdf. Accessed August 17, 2009.
55. King NMP. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics. 2000 ; 28 (4). 332-343.
56. Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007 ; 4 (11). e324.
57. Dresser R. The ubiquity and utility of the therapeutic misconception. Soc Philos Policy. 2002 ; 19 (2). 271-294.
58. -57 Federal Register 13250-13259 ; 1992.
59. US National Institutes of Health. Understanding Clinical Trials. Bethesda, MD: United States National Institutes of Health. http:// clinicaltrials.gov/ct2/info/understand. Accessed August 21, 2009.
60. Applebaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB. 2004 ; 26 (2). 1-8.
61. Institute of Medicine. Conflict of Interest in Medical Research, Education and Practice. Washington, DC: National Academies Press ; 2009. http://www.iom.edu/CMS/3740/47464/65721.aspx. Accessed September 12, 2009.
62. Groeger JS, Barnes M. Conflict of interest in human subjects research. Crit Care Med. 2003 ; 31 (3suppl). S137 - S142.
63. US Department of Health and Human Services. 42 CRF 50 Subpart F: Objectivity in Research. http://grants.nih.gov/grants/guide/notice-files/not95- 179.html. Accessed August 20, 2009.
64. US Food and Drug Administration. 21 CRF 54: Financial Disclosure by Clinical Investigators. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/ CFRSearch.cfm?fr.54.1. Accessed August 20, 2009.
65. Weinfurt KP, Dinan MA, Allsbrook JS, et al. Policies of academic medical centers for disclosing conflicts of interest to potential research participants. Acad Med. 2006 ; 81 (2). 113-118.
66. Ehringhaus SH, Weissman JS, Sears JL, Goold SD, Feibelmann S., Campbell EG Responses of medical schools to institutional conflicts of interest. JAMA. 2008 ; 299 (6). 665-671. (Pubitemid 351252724)
67. Moore v. Regents of the University of California, 793 P.2d 479 (Cal.1990).
68. Gelsinger v Trustees of the University of Pennsylvania. Phila Cnty Ct of CP filed September 18, 2000. Sherman, Silverstein, Kohl, Rose and Podelsky law offices. http://www.sskrplaw.com/ links/healthcare2.html. Accessed September 12, 2009.
69. Milstein A., Pogust H., Mongeluzzi RJ, Bendesky L. Gelsinger Complaint; 2000. http://www.sskrplaw.com/links/healthcare2.html. Accessed August 20, 2009.
70. American Association of Medical Colleges (AAMC) Task Force on Financial Conflicts of Interest in Clinical Research. Protecting Patients, Preserving Integrity, Advancing Health: accelerating the Implementation of COI Policies in Human Subjects Research. Washington, DC: AAMC. http://www.aamc.org/ jointcoireport. Accessed August 20, 2009.
71. US Department of Health and Human Services. Financial Relationships and Interests in Research Involving Human Subjects: guidance for Human Subject Protection; 2004. http://ohrp.osophs.dhhs.gov/humansubjects/finreltn/finalguid. pdf. Accessed August 20, 2009.
72. Physicians Payments Sunshine Act of 2009. Senate Bill S.309. http://thomas.loc.gov/. Accessed September 13, 2009.
73. Hansen D. Senate hearing questions doctors' ties to medical device makers. Am Med News. 2008. http://www.ama-assn.org/amednews/2008/03/17/gvsb0317. htm. Accessed October 2, 2009.
74. Weinfurt KP, Hall MA, King NMP, et al. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 ; 361 (9). 916-921.
75. -74 Federal Register 21610-21613; 2009.
76. N. Thakur. Special Assistant to the NIH Deputy Director for Extramural Research. Personal communication.
77. Silverman H., Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med. 2001 ; 29 (2). 235-241. (Pubitemid 32171764)
78. Institute of Medicine. Beyond the HIPAA Privacy Rule: enhancing Privacy, Improving Health Through Research. Washington, DC: The National Academies Press ; 2009.
79. Frost N., Levine RJ The dysregulation of human subjects research. JAMA. 2007 ; 298 (18). 2196-2198. (Pubitemid 350106660)
80. Controlling research trials. N Engl J Med. 2003 ; 348 (14). 1377-1380. (Pubitemid 36384106)
81. Koski G. Ethics, science, and oversight of critical care research: the Office for Human Research Protections. Am J Respir Crit Care Med. 2004 ; 169 (9). 982-986. (Pubitemid 38543634)
82. Lo B., Groman M. Oversight and quality improvement: focusing on benefits and risks. Arch Intern Med. 2003 ; 163 (12). 1481-1486. (Pubitemid 36758922)
83. Lynn J., Baily MA, Bottrell M., et al. The ethics of using quality improvement methods in health care. Ann Intern Med. 2007 ; 146 (9). 666-673. (Pubitemid 351650521)
84. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2008 ; 355 (26). 2725-2732.
85. US Department of Health and Human Services. News release: OHRP concludes case regarding Johns Hopkins University research on hospital infections; encourages continuance of work to reduce incidence of catheter-related infections; offers new guidance for future research; 2008. www.hhs.gov/ohrp/ news/recentnews.html#20080215. Accessed August 17, 2009.
86. US Department of Health and Human Services. OHRP quality improvement activities frequently asked questions; 2008. http://www.hhs.gov/ohrp/qualityfaq. html. Accessed August 17, 2009.
87. Gawande A. A lifesaving checklist. New York Times. 2007 ; December 30: A8.
88. US Department of Health and Human Services. OHRP statement regarding the New York Times op-ed entitled ''A lifesaving checklist'' ; 2007. http://www.hhs.gov/ohrp/news/recentnews.html#20080115. Accessed August 17, 2009.
89. Miller FG, Emanuel EJ Quality improvement and informed consent. N Engl J Med. 2008 ; 358 (8). 765-7.
90. Savel RH, Goldstein EV, Gopper MA Critical care checklists, the Keystone Project, and Office for Human Research Protections: a case for streamlining the approval process in quality-improvement research. Crit Care Med. 2009 ; 37 (2). 725-728.
91. Holm MJ, Selvan M., Smith ML, et al. Quality improvement or research: defining and supervising QI at the University of Texas M.D. Anderson Cancer Center. In: Jennings B, Baily MA, Lynn J, eds. Health Care Quality Improvement: Ethical and Regulatory Issues. Garrison, NY: The Hastings Center ; 2007: 145-168.
92. Truog RD Ethical assessment of pediatric research protocols. Intensive Care Med. 2008 ; 34 (1). 198-202.